Mitochondria-to-Nucleus Signaling in Colorectal Cancer

结直肠癌中的线粒体到细胞核的信号转导

基本信息

项目摘要

PROJECT SUMMARY This project responds directly to PAR-17-203 “Inter-organelle Communication in Cancer.” A new pathway was discovered called the “mtDNA-IRDS” pathway, through which mitochondria send a stress signal to the nucleus to regulate expression of interferon-stimulated genes (ISGs), which are usually associated with antiviral immunity. The mtDNA-IRDS pathway was elucidated during investigations of a unique mouse model of mtDNA stress caused by haploinsufficiency of the nucleus-encoded mtDNA-packaging factor TFAM (i.e. Tfam+/- mice). These mice have altered mitochondria and nucleoid structures (the mitochondrial version of chromatin) that promotes release of mtDNA into the cytoplasm. The surprising feature of these mice (and cells isolated from them) is that this released mtDNA promotes innate immune signaling, resulting in upregulation of a unique subset of ISGs known as the Interferon-Related DNA-damage resistance Signature (IRDS). The IRDS promotes chemotherapy resistance of tumor cells. The Tfam+/- condition enhances spontaneous intestinal tumorigenesis In the APCMin/+ mouse model of human colorectal cancer (CRC) and new preliminary results show that knock-out of the tumor suppressor commonly mutated in CRC, ARID1A (a subunit of the nuclear SWI/SNF chromatin remodeling complex) also induces the mtDNA-IRDS pathway. Thus, the main premise of this proposal is that the mtDNA-IRDS pathway increases tumorigenesis and/or chemoresistance in CRC, which will be tested through completion of the following three Specific Aims. Aim 1 is to understand how mutations in ARID1A lead to mtDNA-IRDS pathway induction. Aim 2 is to elucidate the mechanism through which the mtDNA-IRDS pathway enhances nuclear DNA repair using the Tfam+/- model of mtDNA-mediated, mitochondria-to-nucleus signaling. Aim 3 is to investigate the role of the mtDNA-IRDS pathway in tumorigenesis and/or chemoresistance in vivo using the Tfam+/-, APCMin/+ and intestinal Arid1a knock-out mouse models of CRC and human CRC tumor samples. That the PARP9-DTX3L complex is a major driver of tumorigenesis and chemoresistance in vivo will be tested by crossing these CRC models to Parp9 knock-out mice. CRC is a leading cause of cancer-related deaths in both men and women, and treatment of this disease is plagued by resistance to chemotherapy. The significance of this proposal is that it probes a novel mechanism of tumorigenesis and chemoresistance due to mtDNA-IRDS pathway activation that has the potential for therapeutic targeting.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Diana Clare Hargreaves其他文献

Diana Clare Hargreaves的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Diana Clare Hargreaves', 18)}}的其他基金

The role of BAF related complexes in regulatory T cell development and function
BAF 相关复合物在调节性 T 细胞发育和功能中的作用
  • 批准号:
    10176397
  • 财政年份:
    2020
  • 资助金额:
    $ 51.01万
  • 项目类别:
The role of BAF related complexes in regulatory T cell development and function
BAF 相关复合物在调节性 T 细胞发育和功能中的作用
  • 批准号:
    10415101
  • 财政年份:
    2020
  • 资助金额:
    $ 51.01万
  • 项目类别:
The role of BAF related complexes in regulatory T cell development and function
BAF 相关复合物在调节性 T 细胞发育和功能中的作用
  • 批准号:
    10632013
  • 财政年份:
    2020
  • 资助金额:
    $ 51.01万
  • 项目类别:
Mitochondria-to-Nucleus Signaling in Colorectal Cancer
结直肠癌中的线粒体到细胞核的信号转导
  • 批准号:
    10300449
  • 财政年份:
    2019
  • 资助金额:
    $ 51.01万
  • 项目类别:
Mitochondria-to-Nucleus Signaling in Colorectal Cancer
结直肠癌中的线粒体到细胞核的信号转导
  • 批准号:
    10061567
  • 财政年份:
    2019
  • 资助金额:
    $ 51.01万
  • 项目类别:
Epigenetic regulation of embryonic stem cells by ATP-dependent BAF chromatin remodeling complexes
ATP依赖性BAF染色质重塑复合物对胚胎干细胞的表观遗传调控
  • 批准号:
    10226169
  • 财政年份:
    2018
  • 资助金额:
    $ 51.01万
  • 项目类别:
Epigenetic regulation of embryonic stem cells by ATP-dependent BAF chromatin remodeling complexes
ATP依赖性BAF染色质重塑复合物对胚胎干细胞的表观遗传调控
  • 批准号:
    9754199
  • 财政年份:
    2018
  • 资助金额:
    $ 51.01万
  • 项目类别:
Epigenetic regulation of embryonic stem cells by ATP-dependent BAF chromatin remodeling complexes
ATP依赖性BAF染色质重塑复合物对胚胎干细胞的表观遗传调控
  • 批准号:
    9980939
  • 财政年份:
    2018
  • 资助金额:
    $ 51.01万
  • 项目类别:
Epigenetic regulation of embryonic stem cells by ATP-dependent BAF chromatin remodeling complexes
ATP依赖性BAF染色质重塑复合物对胚胎干细胞的表观遗传调控
  • 批准号:
    10455634
  • 财政年份:
    2018
  • 资助金额:
    $ 51.01万
  • 项目类别:
Epigenetic regulation of embryonic stem cells by ATP-dependent BAF chromatin remodeling complexes
ATP依赖性BAF染色质重塑复合物对胚胎干细胞的表观遗传调控
  • 批准号:
    9932049
  • 财政年份:
    2018
  • 资助金额:
    $ 51.01万
  • 项目类别:

相似海外基金

Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    9251557
  • 财政年份:
    2016
  • 资助金额:
    $ 51.01万
  • 项目类别:
GUT BARRIER DYSFUNCTION: THE TRIGGER FOR CACHEXIA IN APCMIN/+ MICE
肠道屏障功能障碍:APCMIN/小鼠恶病质的触发因素
  • 批准号:
    7959766
  • 财政年份:
    2009
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    7790516
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    7466689
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    9228937
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    8695594
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    9432821
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    7619472
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Cachexia in ApcMin/+ mice: The role of IL-6
ApcMin/ 小鼠恶病质:IL-6 的作用
  • 批准号:
    8076372
  • 财政年份:
    2008
  • 资助金额:
    $ 51.01万
  • 项目类别:
Impact of P-Glyoprotein inhibition by flavonoids on topotecan-induced apoptosis in intestinal tumors of APCmin/+ mice
类黄酮抑制 P-糖蛋白对拓扑替康诱导的 APCmin/小鼠肠道肿瘤细胞凋亡的影响
  • 批准号:
    23241654
  • 财政年份:
    2006
  • 资助金额:
    $ 51.01万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了